HK1105662A1 - Sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell - Google Patents

Sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell

Info

Publication number
HK1105662A1
HK1105662A1 HK07109453.4A HK07109453A HK1105662A1 HK 1105662 A1 HK1105662 A1 HK 1105662A1 HK 07109453 A HK07109453 A HK 07109453A HK 1105662 A1 HK1105662 A1 HK 1105662A1
Authority
HK
Hong Kong
Prior art keywords
sequences
natural
allowing
function
eukaryotic cell
Prior art date
Application number
HK07109453.4A
Other languages
English (en)
Inventor
Andre Choulika
Jean-Francois Nicolas
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of HK1105662A1 publication Critical patent/HK1105662A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK07109453.4A 1995-08-07 2007-08-30 Sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell HK1105662A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9509587A FR2737731B1 (fr) 1995-08-07 1995-08-07 Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote

Publications (1)

Publication Number Publication Date
HK1105662A1 true HK1105662A1 (en) 2008-02-22

Family

ID=9481767

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07109453.4A HK1105662A1 (en) 1995-08-07 2007-08-30 Sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell

Country Status (12)

Country Link
US (2) US6200800B1 (de)
EP (2) EP0843732B1 (de)
JP (2) JP4173543B2 (de)
AT (2) ATE339511T1 (de)
CA (1) CA2226301C (de)
DE (2) DE69636546T2 (de)
DK (1) DK0843732T3 (de)
ES (1) ES2276407T3 (de)
FR (1) FR2737731B1 (de)
HK (1) HK1105662A1 (de)
PT (1) PT843732E (de)
WO (1) WO1997006271A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737731B1 (fr) * 1995-08-07 1997-10-10 Pasteur Institut Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote
US6534314B1 (en) 1996-06-14 2003-03-18 Massachusetts Institute Of Technology Methods and compositions for transforming cells
US5928914A (en) * 1996-06-14 1999-07-27 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Methods and compositions for transforming cells
US6410317B1 (en) * 1999-07-14 2002-06-25 Clontech Laboratories, Inc. Recombinase-based methods for producing expression vectors and compositions for use in practicing the same
GB2355459B (en) * 1999-11-29 2001-09-26 Isis Innovation A dominant conditional lethal genetic system
EP1274854B1 (de) * 2000-04-12 2009-04-08 Dana-Farber Cancer Institute Selbstlöschende rekombinasen, dafür kodierende nukleinsäuren und verfahren zu deren verwendung
US20040231006A1 (en) * 2000-04-12 2004-11-18 Silver Daniel P. Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
AU2001263160A1 (en) 2000-05-19 2001-12-03 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution
GB2402675B (en) * 2003-05-12 2008-02-20 Oxitec Ltd Resistance dilution
GB2403475B (en) * 2003-07-01 2008-02-06 Oxitec Ltd Stable integrands
GB2404382B (en) * 2003-07-28 2008-01-30 Oxitec Ltd Pest control
EP2392657B1 (de) * 2005-07-05 2013-09-25 The Chemo-Sero-Therapeutic Research Institute Modifizierter Transposonvektor und seine Verwendung
GB2443186A (en) 2006-10-25 2008-04-30 Oxitec Ltd Expression system for mediating alternative splicing
GB2500113A (en) 2012-03-05 2013-09-11 Oxitec Ltd Arthropod male germline gene expression system
GB201303932D0 (en) 2013-03-05 2013-04-17 Oxitec Ltd Muscle actin promoter
GB2526867A (en) 2014-06-05 2015-12-09 Oxitec Ltd Gene expression system
WO2018029534A1 (en) 2016-08-12 2018-02-15 Oxitec Ltd. A self-limiting, sex-specific gene and methods of using

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61502885A (ja) 1984-08-06 1986-12-11 ヒル．ロバ−ト ロツク式チユ−ブ巻取り装置
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
ATE83008T1 (de) * 1987-07-21 1992-12-15 Du Pont Merck Pharma Verfahren fuer die herstellung von in tierischen zellen stabilen und lebensfaehigen rekombinanten viralen vektoren.
FR2629469B1 (fr) * 1988-03-31 1990-12-21 Pasteur Institut Retrovirus recombinant defectif, son application a l'integration de sequences codantes pour des proteines determinees dans le genome de cultures cellulaires infectables par le retrovirus sauvage correspondant et adns recombinants pour la production de ce retrovirus recombinant
US5658775A (en) * 1988-05-17 1997-08-19 Sloan-Kettering Institute For Cancer Research Double copy retroviral vector
JP3249516B2 (ja) * 1990-10-31 2002-01-21 ソマティクス セラピー コーポレイション 遺伝子治療のためのレトロウイルスのベクター
US5629159A (en) * 1995-06-07 1997-05-13 California Institute Of Technology Immortalization and disimmortalization of cells
FR2737731B1 (fr) * 1995-08-07 1997-10-10 Pasteur Institut Sequence de retroelements naturels ou synthetiques ayant pour fonction de permettre l'insertion de sequences nucleotidiques dans une cellule eucaryote

Also Published As

Publication number Publication date
US6200800B1 (en) 2001-03-13
EP1760154A3 (de) 2007-03-14
ATE477326T1 (de) 2010-08-15
JP4173543B2 (ja) 2008-10-29
FR2737731A1 (fr) 1997-02-14
FR2737731B1 (fr) 1997-10-10
CA2226301A1 (fr) 1997-02-20
DE69638235D1 (de) 2010-09-23
WO1997006271A1 (fr) 1997-02-20
JP4482578B2 (ja) 2010-06-16
DE69636546D1 (de) 2006-10-26
EP0843732B1 (de) 2006-09-13
ATE339511T1 (de) 2006-10-15
US20060269522A1 (en) 2006-11-30
ES2276407T3 (es) 2007-06-16
EP1760154B1 (de) 2010-08-11
DE69636546T2 (de) 2007-08-02
JP2008086321A (ja) 2008-04-17
EP1760154A2 (de) 2007-03-07
PT843732E (pt) 2007-01-31
CA2226301C (fr) 2011-04-19
DK0843732T3 (da) 2007-01-22
EP0843732A1 (de) 1998-05-27
JPH11510391A (ja) 1999-09-14

Similar Documents

Publication Publication Date Title
HK1105662A1 (en) Sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell
EP1895010A3 (de) Auf dem Virus der infektiösen Pferdeanämie (EIAV) basierende Vektoren
GB2331522A (en) Lentiviral vectors
EP1034302A4 (de) De novo oder "universaler" sequenzierungs-array
HK1034283A1 (en) Use of triplex structure dna sequences for transferring nucleotide sequences
GB2369121A (en) Producer cell for the production of retroviral vectors
EP1156108A3 (de) Verwendung einer Exo-Nukleotidprobe in der Genklonierung
ES2010727A6 (es) Metodo para producir lineas celulares que producen anticuerpos monoclonales reactivos frente a determinantes antigenicos de gp110 o de p25 de hiv.
HU9800053D0 (en) Gene primers for the detection of hiv-1
RU98100921A (ru) Праймеры для обнаружения вич-1
EP0578776A4 (de) Hemmung von retroviren mittels zu verpackungssequenzen komplementärer antisense-nukleinsäuren.
EP0801575A4 (de) Retrovirale vektoren zur expression in embryonalen zellen
DE69626032D1 (de) Modifizierung von oligonukleotid-primer-sequenzen zum manipilieren der zugabe von nicht-template-nukleotiden
EP0276591A3 (en) Viral vector and recombinant dna coding for the p25 protein of the aids virus
Ballaun Charakterisierung der spezifischen Interaktion transregulatorischer Proteine humaner Retroviren (HIV-1, HTL-VI) mit ihren RNA-Zielsequenzen.
AU1975988A (en) Cloning and nucleotide sequence determination of the isopenicillin n. synthetase gene from streptomyces clauvigerus
EP0828006A3 (de) Verwendung von cis- und/oder trans-Elementen, um die Wirksamkeit der Transduktion, Integration und/oder Transgene-Expression von Parvoviren zu steigen